The glycemic control and side effects of Empagliflozin on patients with type II diabetes mellitus in tertiary care Hospital. (2023). Journal of Diabetes and Endocrinology Association of Nepal, 7(2), 15-23. https://doi.org/10.3126/jdean.v7i2.63887